{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T03:28:22Z","timestamp":1761017302105,"version":"build-2065373602"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Daiichi Sankyo Co., Ltd"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmacological and Toxicological Methods"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.vascn.2020.106870","type":"journal-article","created":{"date-parts":[[2020,4,27]],"date-time":"2020-04-27T21:40:58Z","timestamp":1588023658000},"page":"106870","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Comprehensive analysis of cardiac function, blood biomarkers and histopathology for milrinone-induced cardiotoxicity in cynomolgus monkeys"],"prefix":"10.1016","volume":"103","author":[{"given":"Katsuyoshi","family":"Chiba","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomomichi","family":"Ishizaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Yoshimatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kei","family":"Mikamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuma","family":"Iguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Shirai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Goto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Sakurai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Tamai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroko","family":"Kataoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miki","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiko","family":"Mori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vascn.2020.106870_bb0005","first-page":"353","article-title":"An analysis of the time-relations of electrocardiograms","volume":"7","author":"Bazett","year":"1920","journal-title":"Heart."},{"issue":"1","key":"10.1016\/j.vascn.2020.106870_bb0010","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.critrevonc.2013.02.007","article-title":"State of the art for cardiotoxicity due to chemotherapy and to targeted therapies: A literature review","volume":"88","author":"Berardi","year":"2013","journal-title":"Critical Reviews in Oncology\/Hematology"},{"key":"10.1016\/j.vascn.2020.106870_bb0015","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.vascn.2016.03.006","article-title":"Evaluation of cardiac function in unrestrained dogs and monkeys using left ventricular dP\/dt","volume":"80","author":"Buchanan","year":"2016","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"issue":"5","key":"10.1016\/j.vascn.2020.106870_bb0020","article-title":"A metabolomic study of rats with doxorubicin-induced cardiomyopathy and Shengmai injection treatment","volume":"10","author":"Chen","year":"2015","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.vascn.2020.106870_bb0025","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1016\/S0026-0495(03)00271-3","article-title":"Milrinone, a selective phosphodiesterase 3 inhibitor, stimulates lipolysis, endogenous glucose production, and insulin secretion","volume":"52","author":"Cheung","year":"2003","journal-title":"Metabolism."},{"key":"10.1016\/j.vascn.2020.106870_bb0030","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1006\/taap.2000.9041","article-title":"Proarrhythmic effects of fluoroquinolone antibacterial agents: In vivo effects as physiologic substrate for torsades","volume":"169","author":"Chiba","year":"2000","journal-title":"Toxicology and Applied Pharmacology"},{"issue":"5","key":"10.1016\/j.vascn.2020.106870_bb0035","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1177\/0192623310374969","article-title":"Time course characterization of serum cardiac troponins, heart fatty acid-binding protein, and morphologic findings with isoproterenol-induced myocardial injury in the rat","volume":"38","author":"Clements","year":"2010","journal-title":"Toxicol Pathol."},{"issue":"4","key":"10.1016\/j.vascn.2020.106870_bb0040","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1111\/bph.12979","article-title":"Physiological, pharmacological and toxicological considerations of drug-induced structural cardiac injury","volume":"172","author":"Cross","year":"2015","journal-title":"British Journal of Pharmacology"},{"issue":"11","key":"10.1016\/j.vascn.2020.106870_bb0045","doi-asserted-by":"crossref","first-page":"6823","DOI":"10.1074\/jbc.272.11.6823","article-title":"Structure, localization, and regulation of cGMP-inhibited phosphodiesterase (PDE3)","volume":"272","author":"Degerman","year":"1997","journal-title":"The Journal of Biological Chemistry"},{"issue":"1","key":"10.1016\/j.vascn.2020.106870_bb0050","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.taap.2012.10.025","article-title":"Development of doxorubicin-induced chronic cardiotoxicity in the B6C3F1 mouse model","volume":"266","author":"Desai","year":"2013","journal-title":"Toxicology and Applied Pharmacology"},{"issue":"2","key":"10.1016\/j.vascn.2020.106870_bb0055","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.taap.2014.10.006","article-title":"Early biomarkers of doxorubicin-induced heart injury in a mouse model","volume":"281","author":"Desai","year":"2014","journal-title":"Toxicology and Applied Pharmacology"},{"issue":"16","key":"10.1016\/j.vascn.2020.106870_bb0060","doi-asserted-by":"crossref","first-page":"6656","DOI":"10.1021\/ac901536h","article-title":"Integrated, nontargeted ultrahigh performance liquid chromatography\/electrospray ionization tandem mass spectrometry platform for the identification and relative quantification of the small-molecule complement of biological systems","volume":"81","author":"Evans","year":"2009","journal-title":"Analytical Chemistry"},{"issue":"3","key":"10.1016\/j.vascn.2020.106870_bb0065","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.pharmthera.2013.03.005","article-title":"Drug attrition during pre-clinical and clinical development: Understanding and managing drug-induced cardiotoxicity","volume":"138","author":"Ferri","year":"2013","journal-title":"Pharmacology & Therapeutics"},{"issue":"1","key":"10.1016\/j.vascn.2020.106870_bb0070","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/toxsci\/kfv222","article-title":"Paving the route to plasma miR-208a-3p as an acute cardiac injury biomarker: Preclinical rat data supports its use in drug safety assessment","volume":"149","author":"Glineur","year":"2016","journal-title":"Toxicological Sciences"},{"key":"10.1016\/j.vascn.2020.106870_bb0075","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.vascn.2015.02.002","article-title":"The evaluation of drug-induced changes in cardiac inotropy in dogs: Results from a HESI-sponsored consortium","volume":"75","author":"Guth","year":"2015","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"issue":"2","key":"10.1016\/j.vascn.2020.106870_bb0080","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.toxlet.2004.10.008","article-title":"Effect of milrinone on echocardiographic parameters after single dose in Beagle dogs and relationship with drug-induced cardiotoxicity","volume":"155","author":"Hanton","year":"2005","journal-title":"Toxicology Letters"},{"issue":"5\u20136","key":"10.1016\/j.vascn.2020.106870_bb0085","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.cca.2009.12.009","article-title":"Cardiac troponin may be released by ischemia alone, without necrosis","volume":"411","author":"Hickman","year":"2010","journal-title":"Clinica Chimica Acta"},{"issue":"3","key":"10.1016\/j.vascn.2020.106870_bb0090","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1177\/1091581817704975","article-title":"Comprehensive analysis of circulating microRNA specific to the liver, heart, and skeletal muscle of Cynomolgus monkeys","volume":"36","author":"Iguchi","year":"2017","journal-title":"International Journal of Toxicology"},{"key":"10.1016\/j.vascn.2020.106870_bb0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vascn.2016.10.004","article-title":"Promising approach for the preclinical assessment of cardiac risks using left ventricular pressure-volume loop analyses in anesthetized monkeys","volume":"84","author":"Ishizaka","year":"2017","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"key":"10.1016\/j.vascn.2020.106870_bb0100","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/821823","article-title":"Utility of circulating microRNAs as clinical biomarkers for cardiovascular diseases","author":"Kondkar","year":"2015","journal-title":"BioMed Research International"},{"issue":"4","key":"10.1016\/j.vascn.2020.106870_bb0105","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/j.1476-5381.2011.01255.x","article-title":"How can we improve our understanding of cardiovascular safety liabilities to develop safer medicines?","volume":"163","author":"Laverty","year":"2011","journal-title":"British Journal of Pharmacology"},{"issue":"4","key":"10.1016\/j.vascn.2020.106870_bb0110","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1177\/0192623316638445","article-title":"Recommended diagnostic approach to documenting and reporting skin findings of nonhuman primates from regulatory toxicity studies","volume":"44","author":"Mecklenburg","year":"2016","journal-title":"Toxicologic Pathology"},{"issue":"6","key":"10.1016\/j.vascn.2020.106870_bb0115","doi-asserted-by":"crossref","first-page":"589","DOI":"10.2131\/jts.34.589","article-title":"Characteristics of troponins as myocardial damage biomarkers in cynomolgus monkeys","volume":"34","author":"Minomo","year":"2009","journal-title":"The Journal of Toxicological Sciences"},{"key":"10.1016\/j.vascn.2020.106870_bb0120","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.vascn.2013.04.006","article-title":"Intravenous solid tip ECG lead placement in telemetry implanted dogs: Part 2: High quality telemetry signals yield high sensitivity to drug-induced changes","volume":"68","author":"Mitchell","year":"2013","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"issue":"2","key":"10.1016\/j.vascn.2020.106870_bb0125","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.vascn.2009.05.008","article-title":"Assessment of the pharmacological effects of inotropic drugs on left ventricular pressure and contractility: An evaluation of the QA interval as an indirect indicator of cardiac inotropism","volume":"60","author":"Norton","year":"2009","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"author":"PMDA drug interview form","key":"10.1016\/j.vascn.2020.106870_bb0130"},{"issue":"1","key":"10.1016\/j.vascn.2020.106870_bb0135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0169567","article-title":"Protective effects of dexrazoxane against doxorubicin-induced cardiotoxicity: A metabolomic study","volume":"12","author":"QuanJun","year":"2017","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.vascn.2020.106870_bb0140","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1177\/0192623316663865","article-title":"Assessment of cardiac troponin I responses in nonhuman primates during restraint, blood collection, and dosing in preclinical safety studies","volume":"45","author":"Reagan","year":"2017","journal-title":"Toxicologic Pathology"},{"key":"10.1016\/j.vascn.2020.106870_bb0145","doi-asserted-by":"crossref","first-page":"6994","DOI":"10.18632\/oncotarget.14355","article-title":"Circulating miR-1 as a potential biomarker of doxorubicin-induced cardiotoxicity in breast cancer patients","volume":"8","author":"Rigaud","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.vascn.2020.106870_bb0150","doi-asserted-by":"crossref","first-page":"H1224","DOI":"10.1152\/ajpheart.00828.2016","article-title":"Diminished responsiveness to dobutamine as an inotrope in mice with cecal ligation and puncture-induced sepsis: attribution to phosphodiesterase 4 upregulation","volume":"312","author":"Sakai","year":"2017","journal-title":"American Journal of Physiology. Heart and Circulatory Physiology"},{"issue":"3","key":"10.1016\/j.vascn.2020.106870_bb0155","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/vcp.12272","article-title":"Longitudinal studies of cardiac troponin I concentrations in serum from male cynomolgus monkeys: resting values and effects of oral and intravenous dosing on biologic variability","volume":"44","author":"Schultze","year":"2015","journal-title":"Veterinary Clinical Pathology"},{"issue":"6","key":"10.1016\/j.vascn.2020.106870_bb0160","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/S0002-9629(15)41723-9","article-title":"Milrinone: Basic and clinical pharmacology and acute and chronic management","volume":"311","author":"Shipley","year":"1996","journal-title":"The American Journal of the Medical Sciences"},{"issue":"7","key":"10.1016\/j.vascn.2020.106870_bb0165","doi-asserted-by":"crossref","first-page":"567","DOI":"10.2165\/00002018-200629070-00003","article-title":"Heart failure induced by non-cardiac drugs","volume":"29","author":"Sl\u00f8rdal","year":"2006","journal-title":"Drug Safety"},{"key":"10.1016\/j.vascn.2020.106870_bb0170","doi-asserted-by":"crossref","first-page":"5909","DOI":"10.1021\/pr500835w","article-title":"Quantitative proteomics for cardiac biomarker discovery using isoproterenol-treated nonhuman primates","volume":"13","author":"Song","year":"2014","journal-title":"Journal of Proteome Research"},{"issue":"4","key":"10.1016\/j.vascn.2020.106870_bb0175","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1097\/CCO.0b013e32833ab6f1","article-title":"Insights into cardiovascular side-effects of modern anticancer therapeutics","volume":"22","author":"Stortecky","year":"2010","journal-title":"Current Opinion in Oncology"},{"issue":"7","key":"10.1016\/j.vascn.2020.106870_bb0180","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0040395","article-title":"Perturbation of microRNAs in rat heart during chronic doxorubicin treatment","volume":"7","author":"Vacchi-Suzzi","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.vascn.2020.106870_bb0185","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0052442","article-title":"Heart structure-specific transcriptomic atlas reveals conserved microRNA-mRNA interactions","volume":"8","author":"Vacchi-Suzzi","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.vascn.2020.106870_bb0190","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1517\/14740338.2013.745851","article-title":"Nonclinical strategy considerations for safety pharmacology: Evaluation of biopharmaceuticals","volume":"12","author":"Vargas","year":"2013","journal-title":"Expert Opinion on Drug Safety"},{"author":"Woodcock","key":"10.1016\/j.vascn.2020.106870_bb0195"},{"issue":"2","key":"10.1016\/j.vascn.2020.106870_bb0200","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1007\/s11306-012-0482-9","article-title":"Translational biomarker discovery in clinical metabolomics: An introductory tutorial","volume":"9","author":"Xia","year":"2013","journal-title":"Metabolomics."},{"key":"10.1016\/j.vascn.2020.106870_bb0205","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1007\/s00210-018-1527-z","article-title":"Cardioprotective and functional effects of levosimendan and milrinone in mice with cecal ligation and puncture-induced sepsis","volume":"391","author":"Yamashita","year":"2018","journal-title":"Naunyn-Schmiedeberg\u2019s Archives of Pharmacology"}],"container-title":["Journal of Pharmacological and Toxicological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056871920301994?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056871920301994?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:03:56Z","timestamp":1761005036000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1056871920301994"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":41,"alternative-id":["S1056871920301994"],"URL":"https:\/\/doi.org\/10.1016\/j.vascn.2020.106870","relation":{},"ISSN":["1056-8719"],"issn-type":[{"type":"print","value":"1056-8719"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comprehensive analysis of cardiac function, blood biomarkers and histopathology for milrinone-induced cardiotoxicity in cynomolgus monkeys","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmacological and Toxicological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vascn.2020.106870","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106870"}}